{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:20:49Z","timestamp":1793830849417,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska Universitetssjukhuset","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003849","name":"IngaBritt och Arne Lundbergs Forskningsstiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003849","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00198-025-07588-w","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T11:26:50Z","timestamp":1752233210000},"page":"1649-1659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effect of FRAXplus adjustments on fracture risk reclassification in older Swedish women\u2014results from the SUPERB-study"],"prefix":"10.1007","volume":"36","author":[{"given":"M.","family":"Zoulakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. C.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. F.","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Litsne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vandenput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. V.","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Kanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0749-1431","authenticated-orcid":false,"given":"Mattias","family":"Lorentzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"7588_CR1","doi-asserted-by":"publisher","unstructured":"Kanis JA (2019) Diagnosis and clinical aspects of osteoporosis. In: Ferrari SL, Roux C, eds. Pocket Reference to Osteoporosis. Springer International Publishing 11\u201320. https:\/\/doi.org\/10.1007\/978-3-319-26757-9_2","DOI":"10.1007\/978-3-319-26757-9_2"},{"issue":"1","key":"7588_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/13697137.2021.1951206","volume":"25","author":"M Lorentzon","year":"2022","unstructured":"Lorentzon M, Johansson H, Harvey NC et al (2022) Osteoporosis and fractures in women: the burden of disease. Climacteric 25(1):4\u201310. https:\/\/doi.org\/10.1080\/13697137.2021.1951206","journal-title":"Climacteric"},{"issue":"4","key":"7588_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/joim.12873","volume":"285","author":"M Lorentzon","year":"2019","unstructured":"Lorentzon M (2019) Treating osteoporosis to prevent fractures: current concepts and future developments. J Intern Med 285(4):381\u2013394. https:\/\/doi.org\/10.1111\/joim.12873","journal-title":"J Intern Med"},{"issue":"3","key":"7588_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jocd.2017.06.022","volume":"20","author":"JA Kanis","year":"2017","unstructured":"Kanis JA, Harvey NC, Johansson H, Od\u00e9n A, Leslie WD, McCloskey EV (2017) FRAX Update. J Clin Densitom 20(3):360\u2013367. https:\/\/doi.org\/10.1016\/j.jocd.2017.06.022","journal-title":"J Clin Densitom"},{"issue":"1","key":"7588_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","volume":"17","author":"CL Gregson","year":"2022","unstructured":"Gregson CL, Armstrong DJ, Bowden J et al (2022) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 17(1):58. https:\/\/doi.org\/10.1007\/s11657-022-01061-5","journal-title":"Arch Osteoporos"},{"issue":"10","key":"7588_CR6","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00198-022-06435-6","volume":"33","author":"L Vandenput","year":"2022","unstructured":"Vandenput L, Johansson H, McCloskey EV et al (2022) Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan. Osteoporos Int 33(10):2103\u20132136. https:\/\/doi.org\/10.1007\/s00198-022-06435-6","journal-title":"Osteoporos Int"},{"issue":"4","key":"7588_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11914-010-0032-1","volume":"8","author":"SL Silverman","year":"2010","unstructured":"Silverman SL, Calderon AD (2010) The utility and limitations of FRAX: A US Perspective. Curr Osteoporos Rep 8(4):192\u2013197. https:\/\/doi.org\/10.1007\/s11914-010-0032-1","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"7588_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s40618-023-02219-9","volume":"47","author":"M Schini","year":"2023","unstructured":"Schini M, Johansson H, Harvey NC, Lorentzon M, Kanis JA, McCloskey EV (2023) An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis. J Endocrinol Invest 47(3):501\u2013511. https:\/\/doi.org\/10.1007\/s40618-023-02219-9","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"7588_CR9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00198-020-05517-7","volume":"31","author":"JA Kanis","year":"2020","unstructured":"Kanis JA, Johansson H, Harvey NC et al (2020) Adjusting conventional FRAX estimates of fracture probability according to the recency of sentinel fractures. Osteoporos Int 31(10):1817\u20131828. https:\/\/doi.org\/10.1007\/s00198-020-05517-7","journal-title":"Osteoporos Int"},{"issue":"5","key":"7588_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00223-014-9911-2","volume":"95","author":"H Johansson","year":"2014","unstructured":"Johansson H, Kanis JA, Od\u00e9n A et al (2014) Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women: a meta-analysis of international cohorts. Calcif Tissue Int 95(5):428\u2013435. https:\/\/doi.org\/10.1007\/s00223-014-9911-2","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"7588_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00198-022-06633-2","volume":"34","author":"JA Kanis","year":"2023","unstructured":"Kanis JA, Johansson H, Harvey NC et al (2023) Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year. Osteoporos Int 34(3):479\u2013487. https:\/\/doi.org\/10.1007\/s00198-022-06633-2","journal-title":"Osteoporos Int"},{"issue":"2","key":"7588_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1210\/jc.2018-02054","volume":"104","author":"BAM Larsson","year":"2019","unstructured":"Larsson BAM, Sundh D, Mellstrom D, Axelsson KF, Nilsson AG, Lorentzon M (2019) Association between cortical bone microstructure and statin use in older women. J Clin Endocrinol Metab 104(2):250\u2013257. https:\/\/doi.org\/10.1210\/jc.2018-02054","journal-title":"J Clin Endocrinol Metab"},{"key":"7588_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2024.117204","volume":"187","author":"M Zoulakis","year":"2024","unstructured":"Zoulakis M, Axelsson KF, Litsne H, Johansson L, Lorentzon M (2024) Real-world effectiveness of osteoporosis screening in older Swedish women (SUPERB). Bone 187:117204. https:\/\/doi.org\/10.1016\/j.bone.2024.117204","journal-title":"Bone"},{"issue":"6","key":"7588_CR14","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00198-019-04872-4","volume":"30","author":"M Lorentzon","year":"2019","unstructured":"Lorentzon M, Nilsson AG, Johansson H, Kanis JA, Mellstr\u00f6m D, Sundh D (2019) Extensive undertreatment of osteoporosis in older Swedish women. Osteoporos Int 30(6):1297\u20131305. https:\/\/doi.org\/10.1007\/s00198-019-04872-4","journal-title":"Osteoporos Int"},{"issue":"3","key":"7588_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00198-010-1524-7","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Johansson H, Oden A, McCloskey EV (2011) Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int 22(3):809\u2013816. https:\/\/doi.org\/10.1007\/s00198-010-1524-7","journal-title":"Osteoporos Int"},{"issue":"11","key":"7588_CR16","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/jbmr.3538","volume":"33","author":"WD Leslie","year":"2018","unstructured":"Leslie WD, Johansson H, McCloskey E, Harvey NC, Kanis JA, Hans D (2018) Comparison of methods for improving fracture risk assessment in diabetes: the Manitoba BMD registry. J Bone Miner Res 33(11):1923\u20131930. https:\/\/doi.org\/10.1002\/jbmr.3538","journal-title":"J Bone Miner Res"},{"issue":"6","key":"7588_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s00223-015-9980-x","volume":"96","author":"EV McCloskey","year":"2015","unstructured":"McCloskey EV, Od\u00e9n A, Harvey NC et al (2015) Adjusting fracture probability by trabecular bone score. Calcif Tissue Int 96(6):500\u2013509. https:\/\/doi.org\/10.1007\/s00223-015-9980-x","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"7588_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jocd.2015.07.004","volume":"19","author":"WD Leslie","year":"2016","unstructured":"Leslie WD, Lix LM, Morin SN et al (2016) Adjusting hip fracture probability in men and women using hip axis length: the Manitoba bone density database. J Clin Densitom 19(3):326\u2013331. https:\/\/doi.org\/10.1016\/j.jocd.2015.07.004","journal-title":"J Clin Densitom"},{"issue":"3","key":"7588_CR19","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00198-010-1461-5","volume":"22","author":"WD Leslie","year":"2011","unstructured":"Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2011) Spine\u2013hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement. Osteoporos Int 22(3):839\u2013847. https:\/\/doi.org\/10.1007\/s00198-010-1461-5","journal-title":"Osteoporos Int"},{"issue":"2","key":"7588_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.7326\/m13-1522","volume":"160","author":"MJG Leening","year":"2014","unstructured":"Leening MJG, Vedder MM, Witteman JCM, Pencina MJ, Steyerberg EW (2014) Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician\u2019s guide. Ann Intern Med 160(2):122\u2013131. https:\/\/doi.org\/10.7326\/m13-1522","journal-title":"Ann Intern Med"},{"key":"7588_CR21","doi-asserted-by":"publisher","unstructured":"Pencina MJ, D\u2019 Agostino Sr RB, D\u2019 Agostino Jr RB, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27(2):157\u2013172. https:\/\/doi.org\/10.1002\/sim.2929","DOI":"10.1002\/sim.2929"},{"issue":"15","key":"7588_CR22","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML et al (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377(15):1417\u20131427. https:\/\/doi.org\/10.1056\/NEJMoa1708322","journal-title":"N Engl J Med"},{"issue":"10117","key":"7588_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0140-6736(17)32137-2","volume":"391","author":"DL Kendler","year":"2018","unstructured":"Kendler DL, Marin F, Zerbini CAF et al (2018) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. The Lancet 391(10117):230\u2013240. https:\/\/doi.org\/10.1016\/S0140-6736(17)32137-2","journal-title":"The Lancet"},{"issue":"5","key":"7588_CR24","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/jbmr.2734","volume":"31","author":"EV McCloskey","year":"2016","unstructured":"McCloskey EV, Oden A, Harvey NC et al (2016) A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Min Res 31(5):940\u2013948. https:\/\/doi.org\/10.1002\/jbmr.2734","journal-title":"J Bone Min Res"},{"issue":"2","key":"7588_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00198-011-1846-0","volume":"23","author":"JA Kanis","year":"2012","unstructured":"Kanis JA, Oden A, Johansson H, McCloskey E (2012) Pitfalls in the external validation of FRAX. Osteoporos Int 23(2):423\u2013431. https:\/\/doi.org\/10.1007\/s00198-011-1846-0","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07588-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-025-07588-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07588-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:03:42Z","timestamp":1758747822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-025-07588-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["7588"],"URL":"https:\/\/doi.org\/10.1007\/s00198-025-07588-w","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JA Kanis led the team that developed FRAX as director of the WHO Collaborating Centre for Metabolic Bone Diseases; he is a director of Osteoporosis Research Ltd that maintains FRAX. EV McCloskey, WD Leslie, M Lorentzon, NC Harvey, M Schini, E Liu, L Vandenput, and H Johansson are members of the FRAX team. JA Kanis, NC Harvey, and EV McCloskey are members of the advisory body to the National Osteoporosis Guideline Group. M Schini received funding for her fellowship from the Medical Research Council Centre of Excellence for Musculoskeletal Ageing, from the Osteoporosis 2000 support group, and from Roche Diagnostics and honoraria from MA Health care and Kyowa Kirin\u2014all unrelated to this work.Dr. Johansson received lecture fees from UCB Pharma outside the scope of this work. Dr. Axelsson received personal fees from Amgen, Meda\/Mylan, and Lilly, also outside the scope of this work.EV McCloskey has received consultancy\/lecture fees\/grant funding\/honoraria from AgNovos, Amgen, AstraZeneca, Consilient Healthcare, Fresenius Kabi, Gilead, GSK, Hologic, Internis, Lilly, Merck, Novartis, ObsEva, Pfizer, Radius Health, Redx Oncology, Roche, Sanofi Aventis, UCB, ViiV, Warner Chilcott and I3 Innovus. M. Lorentzon has received lecture fees from Amgen, Astellas, Meda, Jansen-Cilag, Medison Pharma, Gedeon Richter, UCB Pharma, and consulting fees from Amgen, UCB Pharma, Medac, Gedeon Richter, Pharmacosmos, and Parexel International, all outside the presented research. NC Harvey has received consultancy\/lecture fees\/honoraria\/grant funding from Alliance for Better Bone Health, Amgen, MSD, Eli Lilly, Ra- dius Health, Servier, Shire, UCB, Kyowa Kirin, Consilient Healthcare, Theramex, and Internis Pharma. No other conflicts of interest were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The funders were not involved in the design or conduct of the study; the collection, management, analysis, or interpretation of the data; the preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.Drs Zoulakis and Lorentzon had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Role of the funder\/sponsor"}}]}}